We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Life Science Reit Plc | LSE:LABS | London | Ordinary Share | GB00BP5X4Q29 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.40 | 1.02% | 39.80 | 39.80 | 40.20 | 40.10 | 39.50 | 39.90 | 933,022 | 15:27:49 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Real Estate Investment Trust | 15.71M | -27.61M | -0.0789 | -5.04 | 139.3M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/8/2022 16:22 | Bit of volume today but no price change so presume it's shuffling holding | toffeeman | |
02/8/2022 16:54 | Less positively was some recent news at AEWU regarding a sale of one of its life science properties. The property was originally sold for £37m in April but the buyer pulled out and a new buyer came in at £29m. Asked about this at a recent Q&A, the fund manager noted that this was a sector that had become a bit overextended and was not entirely surprised to see them pull out. No idea if this has any significance to LABS but an interesting development. | riverman77 | |
02/8/2022 08:25 | Haven't seen the JPM comment, but there as an interesting article in the FT yesterday about shortage of lab space in the 'golden triangle' of london, Oxford and Cambridge. The need is conversion rather than new build (owing to planning laws). LABS is doing its bit, but hasn't the scale to make much difference; and with the shares trading at a NAV discount, they can't raise new equity. | jonwig | |
02/8/2022 08:13 | Led to believe some positive comment from JP Morgan on the sector yesterday, looks better bid today, may spark some interest.... | chrisdgb | |
18/7/2022 10:31 | I'd say the weakness is largely due to the wider market sell-off rather than anything company specific. Nearly all REITs are down and LABS is actually holding up better than many. Of course rising interest rates are a headwind for the asset class. I'd also heard some suggestions that LABS may have overpaid for assets at the top of the market, and yields they achieved were fairly low. Don't know enough about this sub sector to say whether that's the case. | riverman77 | |
18/7/2022 07:24 | Saltwood - interesting points. a) I think you'll get an updatednav twice a year; that's pretty usual. It's quite a lengthy and expensive exercise. b) Yes, they're doing more development work that is usual for a mere "rent collector". I guess it's part of their model: not enough purpose-built stuff to acquire. c) Do you mean Chapel Road? The thing is that Ironstone have a low profile and probably not much in-house experience. Hope it doesn't recur, as you say. I'd add that the running discount to latest nav of 100.2p is probably down to b). This is riskier than the usual sort of REIT, but the potential rewards are pretty good if they execute well. | jonwig | |
17/7/2022 18:07 | I bought shortly after the IPO and intend to be a long-term investor. Three ideas I have for the recent weakness are: a) We do not have an updated NAV post December 2021. I would expect an uplift but we simply do not know. Ditto on the dividend. b) The strategy seems to depend to a large extent on asset management - ie redevelopment, repurposing existing buildings and, in the case of the Oxford Business Park, construction and development. I imagine inflation of 9%+ will be unkind in these circumstances so costs may be increasing beyond that anticipated. c) Some governance concerns were flagged at the time of the results - I believe this to be a one off issue but clearly concerns about corporate governance destroy value. There are other questions too - for example, the company is fully invested yet has a pipeline of acquisition targets. What is the growth strategy from here? I hope these ideas help. As I say I am very positive on the long term outlook and pleased to hold - indeed, will probably top up at these levels. | saltwood | |
13/7/2022 17:09 | jonwig - Thanks. Have a few shares from IPO. Not feeling clever right now - that's why I'm searching for any specific reasons for the decline. | bathcoup | |
12/7/2022 18:40 | Intention is to convert after 2026: | jonwig | |
12/7/2022 16:42 | "The entire building [7-11 Herbrand Street] is currently let to Thought Machine, one of the UK’s leading fintech companies, until October 2026 at an all-inclusive rent of c. £7.4 million per annum." Thought Machine is hardly "life science"! | bathcoup | |
07/7/2022 09:03 | I bought at the ipo and sold when it retreated to £1. Looking to buy back, but still worried about the recession and whether potential tenants will stay put for now rather than move into LIFE properties. | toffeeman | |
07/7/2022 08:25 | I think so too chrisdgb and have been adding recently. Last reported NAV 100.2p, divi to be announced for period ended Jun 22. Sooner or later this will get back above £1. | gbcol | |
07/7/2022 08:13 | Looking way oversold at these levels, one of the cheapest z scores in the trust sector........ | chrisdgb | |
23/5/2022 08:07 | Results to 31/12: Useful NAV uplift to 100.2p, but rental income not yet enough to cover admin expenses. I guess 31/12 date is the explainer. They don't explain "other admin expenses" which might reduce now they're fully invested. Plenty of useful detail about their investments, including occupancies (81% overall). | jonwig | |
16/5/2022 16:28 | Yes feels a bit premature for a fund raise already. I'd guess at least another year or two away, and only once they've got a decent premium. | riverman77 | |
16/5/2022 13:42 | There will be a NAV statement on 23/05 with their results. They need to get a decent premium in the share price before they can ask for more. But they have bought a substantial amount of development assets, which won't get a nav uplift until they are completed and let. No rush to fundraise, I think. | jonwig | |
16/5/2022 13:21 | Happy with that - they will presumably be back soon for a further raise. | toffeeman | |
16/5/2022 12:17 | Today's purchase means they are now fully invested. | jonwig | |
03/5/2022 18:28 | Yes, that’s my concern too…although they have delayed the results announcement to focus on closing deals so news may be imminent. | saltwood | |
03/5/2022 10:27 | AEWU announced a huge uplift in one of their office assets - turns out this was a life sciences building in Oxford. They also mentioned several parties were interested, suggesting strong demand. Looking good for the sector. My only reservation here is that they are only around 50% invested 6 months after listing. Need to get a move on if the sector really is this hot. | riverman77 | |
10/1/2022 14:01 | FYI - noticed LXI update this morning said Life Sciences was the best performing part of their portfolio (even better than industrials). Haven't really looked at LABS yet but intend to take closer look as soon a I get a chance. | riverman77 | |
24/12/2021 09:22 | Invested here on Monday as I want more exposure to property sector. I think this is an interesting sector and it's run by a very experienced team. | lozzer69 | |
11/12/2021 17:48 | Hasn't exactly taken off but moving in the right direction! | bountyhunter | |
22/11/2021 10:18 | Not a particularly good start to the week for REITs generally... | bountyhunter |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions